Eir Ventures focuses on financing the development of innovative medicine, striving for Nordic innovation to drive global health forward and improve millions of lives while delivering high returns to investors. Their investment strategy centers around a triad of transformative potential, excellence in execution, and scalability, which they apply to every company in their portfolio. They aim to translate rapidly evolving innovations into business opportunities and patient benefits. The firm measures its success by the impact it has on lives and the returns it delivers to its investors. Eir Ventures actively contributes to the progress of their portfolio companies through company creation, board seats, chairpersonships, and even assuming CEO roles when necessary. They emphasize active ownership and syndication with international partners.
Preferred startup development maturity for initial funding deployment.
Life Science, Innovative Medicine, Biopharma, Therapeutics, Diagnostics, Medical Technology, Biotechnology
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...